Sarah Nemec
Comptroller/Controller/Auditor bij BOLT BIOTHERAPEUTICS, INC.
Vermogen: 13 181 $ op 30-04-2024
Profiel
Sarah Nemec is currently the Chief Accounting Officer & Vice President-Finance at Bolt Biotherapeutics, Inc. She previously worked as the VP-Principal Accounting Executive at BioElectron Technology Corp.
from 2016 to 2019.
Ms. Nemec has an undergraduate and graduate degree from The Ohio University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-05-2024 | 11 363 ( 0.03% ) | 13 181 $ | 30-04-2024 |
Actieve functies van Sarah Nemec
Bedrijven | Functie | Begin |
---|---|---|
BOLT BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15-05-2024 |
Eerdere bekende functies van Sarah Nemec
Bedrijven | Functie | Einde |
---|---|---|
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | 01-10-2019 |
Opleiding van Sarah Nemec
The Ohio University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BOLT BIOTHERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Commercial Services |